Results 231 to 240 of about 42,732,117 (303)

De-occluding broadband metalens. [PDF]

Nat Commun
Yoon S, Kang D, Choi E, Lee S, Kim S, Choi M, Heo H, Shin DH, Kwak S, Majumdar A, Rho J, Baek SH.   +11 more
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Comment on "Survival of esophageal squamous cell carcinoma achieving pathological complete response after neoadjuvant immunochemotherapy". [PDF]

J Cancer Res Clin Oncol
Sengan S, Ramaiah S.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Using computer games to explore foraging-predation trade-offs and spatial learning in humans. [PDF]

R Soc Open Sci
Subach S, Dorfman A, Bar A, Potudin T, Subach A, Scharf I.   +5 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

PPDRTL: A novel framework for predicting pollutant deposition on roadside tree leaves using linear regression. [PDF]

PLoS One
Yadav N, Singh SK, Sharma D, Kumar S, Arya V, Alhalabi W, Alsharif H, Gupta BB, Chui KT.   +8 more
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

When Others Agree More Closely: Judgment Similarity Influences Conformity. [PDF]

Cogn Sci
Xu H, Zhang X, Wu J, Yin J.
europepmc   +1 more source

Empowering chemical structures with biological insights for scalable phenotypic virtual screening. [PDF]

Bioinformatics
Lian X, Ma P, Ma T, Ren Z, Cai X, Cheng Z, Song B, Wang H, Pan X, Chen Y, Yuan S, Lin C.   +11 more
europepmc   +1 more source